Tower Research Capital LLC (Trc) Cardiol Therapeutics Inc. Transaction History

Tower Research Capital LLC (Trc)

  • $3.68 Billion
  • Q3 2024

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 10, 2023
BUY
$0.48 - $1.0 $9,084 - $18,926
18,926 Added 536.15%
22,456 $11,000
Q3 2022

Nov 10, 2022
SELL
$1.02 - $1.41 $1,002 - $1,386
-983 Reduced 21.78%
3,530 $4,000
Q2 2022

Aug 15, 2022
BUY
$1.03 - $2.05 $3,422 - $6,812
3,323 Added 279.24%
4,513 $6,000
Q1 2022

May 12, 2022
BUY
$1.25 - $2.31 $1,161 - $2,145
929 Added 355.94%
1,190 $2,000
Q4 2021

Feb 14, 2022
SELL
$1.83 - $4.86 $3,477 - $9,234
-1,900 Reduced 87.92%
261 $0
Q3 2021

Nov 15, 2021
BUY
$2.03 - $4.8 $4,386 - $10,372
2,161 New
2,161 $9,000

Others Institutions Holding CRDL

# of Institutions
45
Shares Held
5.07M
Call Options Held
5.2K
Put Options Held
9.5K
View Full List

About Cardiol Therapeutics Inc.

CRDL Quotes by TradingView
  • Ticker CRDL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 61,942,500
  • Market Cap $98.5M
  • Description
  • Cardiol Therapeutics Inc., a clinical-stage life sciences company, focuses on the research and development of anti-fibrotic and anti-inflammatory therapies for the treatment of cardiovascular disease (CVD). Its lead product is CardiolRx, which is in Phase II/III multi-national, randomized, double-blind, and placebo-controlled study to evaluate t...
More about CRDL
Track This Portfolio

Track Tower Research Capital LLC (Trc) Portfolio

Follow Tower Research Capital LLC (Trc) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email